Concord Healthcare Group Co., Ltd. (HKG:2453)
6.73
+0.32 (4.99%)
Jul 11, 2025, 4:08 PM HKT
Concord Healthcare Group Revenue
In the year 2024, Concord Healthcare Group had annual revenue of 388.31M CNY, down -27.91%. Concord Healthcare Group had revenue of 169.32M in the half year ending December 31, 2024, a decrease of -48.44%.
Revenue
388.31M CNY
Revenue Growth
-27.91%
P/S Ratio
11.97
Revenue / Employee
684.84K CNY
Employees
567
Market Cap
4.95B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 388.31M | -150.35M | -27.91% |
Dec 31, 2023 | 538.65M | 66.48M | 14.08% |
Dec 31, 2022 | 472.17M | 1.67M | 0.35% |
Dec 31, 2021 | 470.51M | 304.18M | 182.89% |
Dec 31, 2020 | 166.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
Sino Biopharmaceutical | 30.72B |
WuXi Biologics | 19.87B |
Akeso | 2.26B |
CSPC Pharmaceutical Group | 28.99B |